Using artificial intelligence to improve radiation treatment for brain tumors
Artificial Intelligence in Radiation Oncology for CNS Tumors
Tata Memorial Centre · NCT06036394
This study is testing whether using artificial intelligence can make radiation treatment for brain tumors more accurate and help doctors predict how well patients will respond to the treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 6000 (estimated) |
| Ages | 1 Year and up |
| Sex | All |
| Sponsor | Tata Memorial Centre (other) |
| Drugs / interventions | radiation |
| Locations | 1 site (Mumbai, Maharashtra) |
| Trial ID | NCT06036394 on ClinicalTrials.gov |
What this trial studies
This observational study aims to enhance the treatment of central nervous system (CNS) tumors through the application of artificial intelligence in radiation oncology. By analyzing medical images and radiation planning data from patients treated at Tata Memorial Centre, the study will utilize advanced algorithms to automatically identify tumor areas and assess treatment responses. The research will involve a retrospective analysis of up to 6000 patients treated with radiotherapy between 2010 and 2022, focusing on improving the accuracy of tumor delineation and predicting patient outcomes. The study will also explore the potential of AI to classify tumors based on prognosis and identify complications arising from radiation therapy.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with CNS tumors who received radiation treatment at Tata Memorial Centre between January 2010 and December 2022.
Not a fit: Patients who received radiation treatment outside of Tata Memorial Centre or those whose radiation planning was not conducted using the treatment planning system will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to more precise radiation treatments, improving outcomes for patients with brain tumors.
How similar studies have performed: Other studies have shown promise in using artificial intelligence for radiation oncology, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: • Patients with CNS tumors treated with radiation in TMC between January 2010 and December 2022. Exclusion Criteria: * RT treatment outside TMC. * Radiation planning not done in the treatment planning system (treated using clinical marking/ conventional simulator).
Where this trial is running
Mumbai, Maharashtra
- Tata Memorial Hospital — Mumbai, Maharashtra, India (RECRUITING)
Study contacts
- Principal investigator: Dr. ARCHYA DASGUPTA, MD — Tata Memorial Hospital
- Study coordinator: Dr ARCHYA DASGUPTA, MD
- Email: archya1010@gmail.com
- Phone: 91-22-24177000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: CNS Tumor, Brain tumor, Glioma, Radiation Oncology, Artificial Intelligence, Machine learning